한 문단으로 보기
Vertex is a large, profitable biotechnology company best known for transforming cystic fibrosis treatment. It partnered with CRISPR Therapeutics on Casgevy and leads its commercialisation, the part of bringing a gene-editing medicine to patients that requires global regulatory, manufacturing and reimbursement capability rather than laboratory science.
Vertex Pharmaceuticals, founded in 1989, is a commercial-stage biotechnology company with a franchise in cystic fibrosis modulators. It collaborated with CRISPR Therapeutics on exagamglogene autotemcel and leads its development and commercialisation. Its presence in the field illustrates a structural point: the scientific origin of an editing medicine and the organisation capable of delivering it globally are frequently not the same company.
Sources
- Vertex Pharmaceuticals
Vertex Pharmaceuticals ↗